Research Topic · Peer-Reviewed

Calcium Antagonist Therapy

Calcium antagonist therapy is a type of medical treatment used to lower blood pressure and reduce the risk of stroke and coronary artery disease. Calcium channel blockers (CCBs) are the type of drug most commonly used during calcium antagonist therapy. These drugs act by blocking the flow of calcium ions into the ce…

Curated from this journal's research 📚 1 peer-reviewed article cited Cited 22× across the literature 🔖 ISSN 2574-4488 🗓 Reviewed July 2026

Overview

Calcium antagonist therapy is a type of medical treatment used to lower blood pressure and reduce the risk of stroke and coronary artery disease. Calcium channel blockers (CCBs) are the type of drug most commonly used during calcium antagonist therapy. These drugs act by blocking the flow of calcium ions into the cells of the heart and blood vessels, which relaxes the muscles in these tissues and reduces the pressure within them. This can help to lower overall systemic blood pressure and reduce the strain on the heart, reducing risk of stroke and coronary artery disease. Calcium antagonist therapy is an important tool for treating high blood pressure and reducing the risk of cardiovascular disease.

Research published in this journal

1 peer-reviewed article, ranked by relevance. Each links to its DOI.

How this research is being cited

The 1 article above has been cited 22 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Calcium Antagonist Therapy, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Nephrology Advances (ISSN 2574-4488).

Journal editorial board
Ying-Yong Zhao · United States Santiago Cuevas · United States Istvan Arany · United States

This page summarises published research for orientation; it is not medical or professional advice.